HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ranjan K Sur Selected Research

Radiotherapy

11/2023Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1α.
1/2015Assessing patient characteristics and radiation-induced non-targeted effects in vivo for high dose-rate (HDR) brachytherapy.
12/2010Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency.
1/2010Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
3/2009Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
2/2003Preliminary report on the effect of brachytherapy on expression of p53, bc1-2 and apoptosis in squamous cell carcinoma of the oesophagus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ranjan K Sur Research Topics

Disease

5Neoplasms (Cancer)
11/2023 - 05/2002
3Carcinoma (Carcinomatosis)
01/2015 - 05/2002
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 03/2009
1Hypoxia (Hypoxemia)
11/2023
1Cholestasis
12/2018
1Cholangiocarcinoma
12/2018
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2010
1Squamous Cell Carcinoma of Head and Neck
01/2010
1Exanthema (Rash)
01/2010
1Brain Neoplasms (Brain Tumor)
03/2009
1Necrosis
02/2003
1Neoplasm Metastasis (Metastasis)
02/2003
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2003
1Squamous Cell Neoplasms (Squamous Cell Cancer)
05/2002
1Esophageal Neoplasms (Esophageal Cancer)
05/2002

Drug/Important Bio-Agent (IBA)

1Protein Kinases (Protein Kinase)IBA
11/2023
1CanagliflozinIBA
11/2023
1Adenosine Monophosphate (AMP)IBA
11/2023
1Phenobarbital (Luminal)FDA Link
12/2010
1Cetuximab (Erbitux)FDA Link
01/2010
1motexafin gadoliniumIBA
03/2009
1hydroxide ionIBA
02/2003
1Free RadicalsIBA
02/2003
1Keratins (Keratin)IBA
02/2003
1BariumIBA
05/2002

Therapy/Procedure

6Radiotherapy
11/2023 - 02/2003
6Brachytherapy
12/2018 - 05/2002
1Palliative Care (Palliative Therapy)
07/2015